Abbreviation | Meaning |
ECG | Electrocardiogram |
QT | Q and T are 2 points on an electrocardiogram |
BP | Blood pressure |
Welcome to the Right Decision Service (RDS) newsletter for October 2024.
Development of the contingency solutions to maximise RDS resilience and minimise risk of future outages is in progress, aiming for completion by Christmas. As a reminder, these contingency arrangements are:
In the meantime, a gentle reminder to encourage users to download essential clinical toolkits to their mobile devices so that there is an offline version always available.
A new scheduled deployment with minor improvements drawn from support tickets, externally funded projects, information related to outages, and feature requests will take place in early December. Key improvements planned are:
We are also seeking approval to use the NHS Scotland logo and title for the RDS app on the app stores to help with audience engagement and clarity around the provenance of RDS.
We are still hopeful that user acceptance testing for at least the Search and browse enhancements can take place before Christmas. Thank you for your patience and understanding in waiting for these improvements. Timescales have been pushed back by old app migration challenges, work to address outages, and most recently implementing the contingency arrangements.
We are aware that there continue to be some issues around a number of RDS support tickets, in part due to constraints around visibility for the RDS team of the tickets in the existing support portal. We are investigating the potential to move to a new support ticket requesting system from early in the new year. We will organise the proposed webinar around support ticket processes once we have confirmed the way forward with the system.
There is a known issue with alterations in formatting of some RDS tables which seems to have arisen as a result of the 17 October deployment. Tactuum is working on a fix and on implementing additional regression testing to prevent this issue recurring.
Recently launched toolkits include:
NHS Lothian Infectious Diseases
Scottish Health Technologies Group – Technology Assessment recommendations
NHS Tayside Anaesthetics and Critical Care projects – an innovative toolkit which uses PowerAutomate to manage review and response to proposals for improvement projects.
If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot
A number of toolkits are expected to go live before Christmas, including:
We have had a good response to the recent invitation to sign up to the new Teams channel for RDS editors. This provides a forum for editors to share learning, ideas and questions and we hope to hold regular webinars on topics of interest. The RDS team is in the process of joining participants to the channel and we’d encourage all editors to take part, using the registration form – available in Providers section of the RDS Learning and Support area.
The RDS team has worked with colleagues in NHS Grampian and the Digital Health & Care Innovation Centre to evaluate the impact of the Prevent the progress of diabetes web and mobile app in a small-scale pilot project. This app provides access to local and national resources and services targeted at people with prediabetes, a history of gestational diabetes, or candidates for remission. After just 8 weeks of using the app, 94% of patients reported increased their knowledge and understanding of diabetes, and 88% said it had increased their confidence and motivation to make lifestyle changes, highlighting specific behaviour changes. The learning from this project is informing development of a service model based on tailored support for patient groups with, high, medium and low digital self-efficacy.
Please contact ann.wales3@nhs.scot if you would like to know more about this project.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
The Right Decision Service: the national decision support platform for Scotland’s health and care
Website: https://rightdecisions.scot.nhs.uk Mobile app download: Apple Android
Base selection on the likely cause, mechanism of action of the drugs available, the side-effect profile of each drug, interactions and concomitant conditions. The information table is not fully comprehensive, for further information refer to guidance below and/or BNF/manufacturers Summary of Product Characteristics:
DRUG CLASS/ ANTIEMETIC |
CAUTION/ CONTRA-INDICATIONS |
GOOD FOR NAUSEA CAUSED BY/OTHER USES |
|
ANTIHISTAMINES |
|||
CYCLIZINE |
Caution Severe heart failure or acute myocardial infarction; may counteract the beneficial haemodynamic effects of opioids. Anticholinergic** |
Movement, ↑ intracranial pressure, mechanical bowel obstruction, post-operative. |
|
PROMETHAZINEQT |
Caution Strongly anticholinergic** |
Movement |
|
PHENOTHIAZINES AND RELATED DRUGS |
|||
PROCHLORPERAZINEQT |
Caution Balance disturbances in older people; may often lead to drug-induced Parkinson’s disease, postural hypotension and mental confusion. Strongly anticholinergic** |
Contra-indication Prochlorperazine injection is considered inappropriate for patients with reduced consciousness due to its tendency to deepen any state of sedation. |
Movement, post-operative.
Buccal formulation available. |
LEVOMEPROMAZINEQT |
Caution Risk of postural hypotension; avoid in ambulant patients over 50 years, unless a risk of hypotensive reaction has been assessed. Anticholinergic** |
Palliative care. |
|
DOMPERIDONE AND METOCLOPRAMIDE |
|||
DOMPERIDONEQT
|
Caution Does not readily cross the blood brain barrier and less likely to exhibit extra-pyramidal effects and sedation compared with metoclopramide, however caution is still recommended in the young, very old and debilitated. Risk of cardiac side-effects; for short term use only (up to 7 days). |
Contra-indication Cardiac conduction is, or could be impaired, or where there is underlying cardiac disease, when administered concomitantly with drugs that prolong the QT interval or potent CYP3A4 inhibitors, and in severe impairment. Gastro-intestinal obstruction. |
Drug induced (eg emergency hormonal contraception, opioids, chemotherapy).
Only antiemetic advised for use in Parkinson’s disease.
Prokinetic. |
METOCLOPRAMIDEQT |
Caution in young, very old and debilitated, due to extrapyramidal effects. Risk of neurological side-effects (up to 5 days only). Anticholinergic** |
Contra-indicated in gastro-intestinal obstruction, post bowel surgery and in Parkinson’s disease. Avoid where emesis and melaena are present. |
Opioids and gastric/hepatic/biliary disease (not GI obstruction).
Prokinetic. |
5HT3 RECEPTOR ANTAGONIST |
|||
ONDANSETRONQT |
Caution Increased large bowel transit time; constipation can be a problem. |
Post-operative, radiotherapy and chemotherapy, palliative care. |
|
HYOSCINE |
|||
HYOSCINE HYDROBROMIDE |
Caution Sedation can be a problematic side-effect if driving or operating machinery. Strongly anticholinergic** |
Motion sickness, bowel obstruction, palliative care. |
|
OTHER |
|||
DEXAMETHASONE |
Caution if history of peptic ulcer disease/ concurrent NSAIDs. Monitor capillary blood glucose in patients with diabetes. |
Post-operative, chemotherapy, ↑ intracranial pressure. Appetite stimulant. |
|
HALOPERIDOLQT |
Caution Requires a baseline ECG prior to treatment and consider the need for ongoing ECG monitoring. Anticholinergic** |
For palliative care (opioid-induced and metabolic causes). |
|
LORAZEPAM |
Caution Addictive potential. |
Short-term use in anticipatory nausea and vomiting. |
QT Avoid in patients with congenital long QT interval. Prolongs QT interval and/or causes torsades de pointes.
See Credible Meds
** Consider the cumulative anticholinergic burden of all medicines. Anticholinergic side-effects include increased risk of urinary retention, falls, BP reduction, confusion, sedation, dementia, glaucoma etc.
(see http://www.uea.ac.uk/mac/comm/media/press/2011/June/Anticholinergics+study+drug+list).
Abbreviation | Meaning |
ECG | Electrocardiogram |
QT | Q and T are 2 points on an electrocardiogram |
BP | Blood pressure |